Latest News - Page 5

Study Finds Gut Microbacteria Influences Liver Disease
BY RACHEL LUTZ
Mutations can weaken the immune system and increase the risk of developing metabolic syndrome.
FDA Grants Priority Review to HCV Combination Therapy
BY LAUREN SANTYE, ASSISTANT EDITOR
Combination drug treats all genotypes of chronic hepatitis C infection.
Geographic Access Issues with Liver Transplantation
BY JEANNETTE Y. WICK, RPH, MBA, FASCP
Issues found in the likelihood of being removed from the transplant list or actually receiving a transplant.
HCV Treatments Among Costliest Drugs Per Medicare Part D Beneficiary
BY ALLISON GILCHRIST, ASSOCIATE EDITOR
New hepatitis C treatments remain costly therapeutic options for patients.
Program May Be Roadmap for Treating Large Populations of HCV Patients
BY BILL SCHU
Ethical questions persist about maintaining high prices for HCV drugs in certain markets while making them more widely and cheaply available in other markets.
Hep C Drugs: Prices to Plummet, but Not in US
BY GALE SCOTT
Major drug companies are starting to make cheap versions of blockbuster hepatitis C drugs available to people in poor and many middle-income nations.
Hepatic Fibrosis Has Strong Genetic Component
BY RACHEL LUTZ
Liver disease is more heritable than body mass index.
Researchers Discover New Human Virus Linked to Hepatitis C
BY CATHERINE KOLONKO
Human pegivirus-2 found only in patients with hepatitis C.
$auto_registration$